B&G FOODS INC (BGS) Fundamental Analysis & Valuation

NYSE:BGS • US05508R1068

Current stock price

5.11 USD
+0.32 (+6.68%)
At close:
5.05 USD
-0.06 (-1.17%)
Pre-Market:

This BGS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BGS Profitability Analysis

1.1 Basic Checks

  • In the past year BGS was profitable.
  • In the past year BGS had a positive cash flow from operations.
  • In the past 5 years BGS reported 4 times negative net income.
  • In the past 5 years BGS always reported a positive cash flow from operatings.
BGS Yearly Net Income VS EBIT VS OCF VS FCFBGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

1.2 Ratios

  • BGS has a worse Return On Assets (-1.53%) than 60.92% of its industry peers.
  • BGS's Return On Equity of -9.55% is on the low side compared to the rest of the industry. BGS is outperformed by 63.22% of its industry peers.
  • The Return On Invested Capital of BGS (5.55%) is better than 64.37% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BGS is in line with the industry average of 7.17%.
Industry RankSector Rank
ROA -1.53%
ROE -9.55%
ROIC 5.55%
ROA(3y)-3.94%
ROA(5y)-2.07%
ROE(3y)-21.78%
ROE(5y)-11.87%
ROIC(3y)5.85%
ROIC(5y)5.35%
BGS Yearly ROA, ROE, ROICBGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • Looking at the Operating Margin, with a value of 10.04%, BGS is in the better half of the industry, outperforming 77.01% of the companies in the same industry.
  • BGS's Operating Margin has declined in the last couple of years.
  • BGS has a Gross Margin (21.81%) which is comparable to the rest of the industry.
  • BGS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.04%
PM (TTM) N/A
GM 21.81%
OM growth 3Y3.14%
OM growth 5Y-6.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.82%
GM growth 5Y-2.28%
BGS Yearly Profit, Operating, Gross MarginsBGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

3

2. BGS Health Analysis

2.1 Basic Checks

  • BGS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • BGS has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BGS has been increased compared to 5 years ago.
  • The debt/assets ratio for BGS is higher compared to a year ago.
BGS Yearly Shares OutstandingBGS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
BGS Yearly Total Debt VS Total AssetsBGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • BGS has an Altman-Z score of 1.40. This is a bad value and indicates that BGS is not financially healthy and even has some risk of bankruptcy.
  • BGS has a Altman-Z score of 1.40. This is in the lower half of the industry: BGS underperforms 62.07% of its industry peers.
  • The Debt to FCF ratio of BGS is 27.56, which is on the high side as it means it would take BGS, 27.56 years of fcf income to pay off all of its debts.
  • BGS has a Debt to FCF ratio (27.56) which is in line with its industry peers.
  • BGS has a Debt/Equity ratio of 4.30. This is a high value indicating a heavy dependency on external financing.
  • BGS has a Debt to Equity ratio of 4.30. This is amonst the worse of the industry: BGS underperforms 85.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.3
Debt/FCF 27.56
Altman-Z 1.4
ROIC/WACC0.73
WACC7.65%
BGS Yearly LT Debt VS Equity VS FCFBGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • BGS has a Current Ratio of 3.32. This indicates that BGS is financially healthy and has no problem in meeting its short term obligations.
  • BGS's Current ratio of 3.32 is amongst the best of the industry. BGS outperforms 86.21% of its industry peers.
  • BGS has a Quick Ratio of 1.43. This is a normal value and indicates that BGS is financially healthy and should not expect problems in meeting its short term obligations.
  • BGS has a Quick ratio of 1.43. This is in the better half of the industry: BGS outperforms 74.71% of its industry peers.
Industry RankSector Rank
Current Ratio 3.32
Quick Ratio 1.43
BGS Yearly Current Assets VS Current LiabilitesBGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1

3. BGS Growth Analysis

3.1 Past

  • BGS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.14%.
  • BGS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -25.75% yearly.
  • Looking at the last year, BGS shows a decrease in Revenue. The Revenue has decreased by -5.37% in the last year.
  • The Revenue has been decreasing by -1.46% on average over the past years.
EPS 1Y (TTM)-27.14%
EPS 3Y-23.07%
EPS 5Y-25.75%
EPS Q2Q%-9.68%
Revenue 1Y (TTM)-5.37%
Revenue growth 3Y-5.44%
Revenue growth 5Y-1.46%
Sales Q2Q%-2.17%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.19% on average over the next years. This is quite good.
  • The Revenue is expected to decrease by -2.90% on average over the next years.
EPS Next Y-0.7%
EPS Next 2Y15.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-8.79%
Revenue Next 2Y-4.55%
Revenue Next 3Y-2.9%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BGS Yearly Revenue VS EstimatesBGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
BGS Yearly EPS VS EstimatesBGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

7

4. BGS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.02, which indicates a very decent valuation of BGS.
  • Based on the Price/Earnings ratio, BGS is valued cheaply inside the industry as 81.61% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of BGS to the average of the S&P500 Index (25.61), we can say BGS is valued rather cheaply.
  • A Price/Forward Earnings ratio of 10.09 indicates a reasonable valuation of BGS.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BGS indicates a rather cheap valuation: BGS is cheaper than 85.06% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.79. BGS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.02
Fwd PE 10.09
BGS Price Earnings VS Forward Price EarningsBGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 62.07% of the companies in the same industry are more expensive than BGS, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BGS indicates a rather cheap valuation: BGS is cheaper than 94.25% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.78
EV/EBITDA 9.22
BGS Per share dataBGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BGS's earnings are expected to grow with 15.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.19%
EPS Next 3YN/A

5

5. BGS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 15.35%, BGS is a good candidate for dividend investing.
  • BGS's Dividend Yield is rather good when compared to the industry average which is at 2.48. BGS pays more dividend than 98.85% of the companies in the same industry.
  • BGS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 15.35%

5.2 History

  • The dividend of BGS decreases each year by -16.37%.
  • BGS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of BGS decreased recently.
Dividend Growth(5Y)-16.37%
Div Incr Years0
Div Non Decr Years1
BGS Yearly Dividends per shareBGS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • BGS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-140.09%
EPS Next 2Y15.19%
EPS Next 3YN/A
BGS Yearly Income VS Free CF VS DividendBGS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

BGS Fundamentals: All Metrics, Ratios and Statistics

B&G FOODS INC

NYSE:BGS (3/25/2026, 8:12:15 PM)

Premarket: 5.05 -0.06 (-1.17%)

5.11

+0.32 (+6.68%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)03-03
Earnings (Next)05-04
Inst Owners64.29%
Inst Owner Change-5.33%
Ins Owners3.72%
Ins Owner Change5.71%
Market Cap408.65M
Revenue(TTM)1.83B
Net Income(TTM)-43.26M
Analysts48.33
Price Target4.67 (-8.61%)
Short Float %13.86%
Short Ratio4.74
Dividend
Industry RankSector Rank
Dividend Yield 15.35%
Yearly Dividend0.76
Dividend Growth(5Y)-16.37%
DP-140.09%
Div Incr Years0
Div Non Decr Years1
Ex-Date03-31
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.98%
Min EPS beat(2)-7.59%
Max EPS beat(2)33.56%
EPS beat(4)1
Avg EPS beat(4)-20.26%
Min EPS beat(4)-74.14%
Max EPS beat(4)33.56%
EPS beat(8)2
Avg EPS beat(8)-18.59%
EPS beat(12)6
Avg EPS beat(12)-5.61%
EPS beat(16)7
Avg EPS beat(16)-4.6%
Revenue beat(2)0
Avg Revenue beat(2)-0.35%
Min Revenue beat(2)-0.45%
Max Revenue beat(2)-0.25%
Revenue beat(4)0
Avg Revenue beat(4)-2.73%
Min Revenue beat(4)-8.34%
Max Revenue beat(4)-0.25%
Revenue beat(8)1
Avg Revenue beat(8)-1.99%
Revenue beat(12)2
Avg Revenue beat(12)-1.78%
Revenue beat(16)4
Avg Revenue beat(16)-1.02%
PT rev (1m)0%
PT rev (3m)1.85%
EPS NQ rev (1m)13.29%
EPS NQ rev (3m)13.29%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-2.43%
Revenue NQ rev (3m)-2.43%
Revenue NY rev (1m)-7.23%
Revenue NY rev (3m)-7.23%
Valuation
Industry RankSector Rank
PE 10.02
Fwd PE 10.09
P/S 0.22
P/FCF 5.78
P/OCF 4.03
P/B 0.9
P/tB N/A
EV/EBITDA 9.22
EPS(TTM)0.51
EY9.98%
EPS(NY)0.51
Fwd EY9.91%
FCF(TTM)0.88
FCFY17.31%
OCF(TTM)1.27
OCFY24.81%
SpS22.87
BVpS5.66
TBVpS-16.03
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.06
Profitability
Industry RankSector Rank
ROA -1.53%
ROE -9.55%
ROCE 7.03%
ROIC 5.55%
ROICexc 5.67%
ROICexgc 17.67%
OM 10.04%
PM (TTM) N/A
GM 21.81%
FCFM 3.87%
ROA(3y)-3.94%
ROA(5y)-2.07%
ROE(3y)-21.78%
ROE(5y)-11.87%
ROIC(3y)5.85%
ROIC(5y)5.35%
ROICexc(3y)5.96%
ROICexc(5y)5.44%
ROICexgc(3y)19.22%
ROICexgc(5y)17.87%
ROCE(3y)7.41%
ROCE(5y)6.78%
ROICexgc growth 3Y8.08%
ROICexgc growth 5Y-7.13%
ROICexc growth 3Y8.56%
ROICexc growth 5Y-2.05%
OM growth 3Y3.14%
OM growth 5Y-6.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.82%
GM growth 5Y-2.28%
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 4.3
Debt/FCF 27.56
Debt/EBITDA 7.79
Cap/Depr 46.28%
Cap/Sales 1.68%
Interest Coverage 1.23
Cash Conversion 40.59%
Profit Quality N/A
Current Ratio 3.32
Quick Ratio 1.43
Altman-Z 1.4
F-Score4
WACC7.65%
ROIC/WACC0.73
Cap/Depr(3y)41.18%
Cap/Depr(5y)40.76%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.14%
EPS 3Y-23.07%
EPS 5Y-25.75%
EPS Q2Q%-9.68%
EPS Next Y-0.7%
EPS Next 2Y15.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.37%
Revenue growth 3Y-5.44%
Revenue growth 5Y-1.46%
Sales Q2Q%-2.17%
Revenue Next Year-8.79%
Revenue Next 2Y-4.55%
Revenue Next 3Y-2.9%
Revenue Next 5YN/A
EBIT growth 1Y-13.81%
EBIT growth 3Y-2.47%
EBIT growth 5Y-7.86%
EBIT Next Year33.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-31.46%
FCF growth 3YN/A
FCF growth 5Y-22.61%
OCF growth 1Y-22.55%
OCF growth 3Y156.62%
OCF growth 5Y-18.47%

B&G FOODS INC / BGS Fundamental Analysis FAQ

What is the fundamental rating for BGS stock?

ChartMill assigns a fundamental rating of 3 / 10 to BGS.


What is the valuation status for BGS stock?

ChartMill assigns a valuation rating of 7 / 10 to B&G FOODS INC (BGS). This can be considered as Undervalued.


What is the profitability of BGS stock?

B&G FOODS INC (BGS) has a profitability rating of 3 / 10.


How financially healthy is B&G FOODS INC?

The financial health rating of B&G FOODS INC (BGS) is 3 / 10.


What is the earnings growth outlook for B&G FOODS INC?

The Earnings per Share (EPS) of B&G FOODS INC (BGS) is expected to decline by -0.7% in the next year.